{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T12:03:24Z","timestamp":1793016204968,"version":"4.5.0"},"reference-count":104,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2021.43730","type":"journal-article","created":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T12:37:30Z","timestamp":1642163850000},"page":"e2143730","source":"Crossref","is-referenced-by-count":67,"title":["Association of Hormonal Contraceptive Use With Adverse Health Outcomes"],"prefix":"10.1001","volume":"5","author":[{"given":"Sharmila","family":"Brabaharan","sequence":"first","affiliation":[{"name":"School of Postgraduate Studies, International Medical University, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajesh K.","family":"Veettil","sequence":"additional","affiliation":[{"name":"Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer E.","family":"Kaiser","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of Utah, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vrosha Rau","family":"Raja Rao","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Sarikei Public Health Clinic, Sarawak, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rujira","family":"Wattanayingcharoenchai","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marikannan","family":"Maharajan","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Putsarat","family":"Insin","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Rajavithi Hospital, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pattarawalai","family":"Talungchit","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thunyarat","family":"Anothaisintawee","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand"},{"name":"Department of Clinical Epidemiology and Biostatistics, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammarin","family":"Thakkinstian","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology and Biostatistics, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathorn","family":"Chaiyakunapruk","sequence":"additional","affiliation":[{"name":"Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City"},{"name":"School of Pharmacy, University of Wisconsin\u2013Madison, Madison"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2022,1,14]]},"reference":[{"issue":"4","key":"zoi211211r2","article-title":"Skin patch and vaginal ring versus combined oral contraceptives for contraception.","volume":"2013","author":"Lopez","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"zoi211211r3","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.bpobgyn.2008.11.008","article-title":"Understanding contraceptive failure.","volume":"23","author":"Trussell","year":"2009","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"8","key":"zoi211211r5","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1503\/cmaj.081086","article-title":"Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses.","volume":"181","author":"Ioannidis","year":"2009","journal-title":"CMAJ"},{"issue":"7","key":"zoi211211r6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"issue":"15","key":"zoi211211r7","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting.","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"issue":"2","key":"zoi211211r8","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.37341","article-title":"Role of diet in colorectal cancer incidence: umbrella review of meta-analyses of prospective observational studies.","volume":"4","author":"Veettil","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"12","key":"zoi211211r9","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1001\/jamapsychiatry.2019.2859","article-title":"Association of antidepressant use with adverse health outcomes: a systematic umbrella review.","volume":"76","author":"Dragioti","year":"2019","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"zoi211211r10","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S1474-4422(14)70267-4","article-title":"Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses.","volume":"14","author":"Belbasis","year":"2015","journal-title":"Lancet Neurol"},{"key":"zoi211211r11","doi-asserted-by":"crossref","first-page":"j4008","DOI":"10.1136\/bmj.j4008","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both.","volume":"358","author":"Shea","year":"2017","journal-title":"BMJ"},{"issue":"5","key":"zoi211211r12","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1111\/jep.2018.24.issue-5","article-title":"The evolution of GRADE (part 3): a framework built on science or faith?","volume":"24","author":"Mercuri","year":"2018","journal-title":"J Eval Clin Pract"},{"issue":"8","key":"zoi211211r13","doi-asserted-by":"publisher","first-page":"543","DOI":"10.7326\/M18-0808","article-title":"Statins and multiple noncardiovascular outcomes: umbrella review of meta-analyses of observational studies and randomized controlled trials.","volume":"169","author":"He","year":"2018","journal-title":"Ann Intern Med"},{"issue":"2","key":"zoi211211r14","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1093\/ndt\/gfw470","article-title":"The association between proton pump inhibitor use and the risk of adverse kidney outcomes: a systematic review and meta-analysis.","volume":"33","author":"Nochaiwong","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"zoi211211r15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1471-2288-14-25","article-title":"The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method.","volume":"14","author":"IntHout","year":"2014","journal-title":"BMC Med Res Methodol"},{"issue":"3","key":"zoi211211r16","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials.","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"issue":"5","key":"zoi211211r17","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1093\/ije\/dyn204","article-title":"Commentary: heterogeneity in meta-analysis should be expected and appropriately quantified.","volume":"37","author":"Higgins","year":"2008","journal-title":"Int J Epidemiol"},{"issue":"7109","key":"zoi211211r18","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test.","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"1","key":"zoi211211r19","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/rssa.2008.172.issue-1","article-title":"A re-evaluation of random-effects meta-analysis.","volume":"172","author":"Higgins","year":"2009","journal-title":"J R Stat Soc Ser A Stat Soc"},{"issue":"8","key":"zoi211211r20","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1001\/archgenpsychiatry.2011.28","article-title":"Excess significance bias in the literature on brain volume abnormalities.","volume":"68","author":"Ioannidis","year":"2011","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"zoi211211r21","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1177\/1740774507079441","article-title":"An exploratory test for an excess of significant findings.","volume":"4","author":"Ioannidis","year":"2007","journal-title":"Clin Trials"},{"issue":"2","key":"zoi211211r22","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jclinepi.2008.05.014","article-title":"Synthesis of observational studies should consider credibility ceilings.","volume":"62","author":"Salanti","year":"2009","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"zoi211211r23","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jclinepi.2014.09.004","article-title":"Application of credibility ceilings probes the robustness of meta-analyses of biomarkers and cancer risk.","volume":"68","author":"Papatheodorou","year":"2015","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"zoi211211r24","article-title":"Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.","author":"Lethaby","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"zoi211211r25","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.metabol.2017.05.001","article-title":"Effects of oral contraceptives on metabolic profile in women with polycystic ovary syndrome: a meta-analysis comparing products containing cyproterone acetate with third generation progestins.","volume":"73","author":"Amiri","year":"2017","journal-title":"Metabolism"},{"issue":"2","key":"zoi211211r26","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S1473-3099(14)71052-7","article-title":"Hormonal contraceptive use and women\u2019s risk of HIV acquisition: a meta-analysis of observational studies.","volume":"15","author":"Ralph","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"zoi211211r27","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007245.pub2","article-title":"Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.","author":"Chin","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"zoi211211r28","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1111\/jch.13042","article-title":"Association between duration of oral contraceptive use and risk of hypertension: a meta-analysis.","volume":"19","author":"Liu","year":"2017","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"1","key":"zoi211211r29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/oxfordjournals.aje.a008846","article-title":"Controversy of oral contraceptives and risk of rheumatoid arthritis: meta-analysis of conflicting studies and review of conflicting meta-analyses with special emphasis on analysis of heterogeneity.","volume":"144","author":"Pladevall-Vila","year":"1996","journal-title":"Am J Epidemiol"},{"issue":"1","key":"zoi211211r30","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0010-7824(03)00073-8","article-title":"Oral contraceptives use and the risk of myocardial infarction: a meta-analysis.","volume":"68","author":"Khader","year":"2003","journal-title":"Contraception"},{"issue":"2","key":"zoi211211r31","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1212\/WNL.51.2.411","article-title":"Oral contraceptives and the risk of subarachnoid hemorrhage: a meta-analysis.","volume":"51","author":"Johnston","year":"1998","journal-title":"Neurology"},{"issue":"6","key":"zoi211211r32","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/S0015-0282(16)58321-6","article-title":"Plasma lipids and desogestrel and ethinyl estradiol: a meta-analysis.","volume":"65","author":"Lobo","year":"1996","journal-title":"Fertil Steril"},{"issue":"5","key":"zoi211211r33","doi-asserted-by":"publisher","first-page":"368","DOI":"10.3109\/00016349209021075","article-title":"Oral contraceptives and cancer of the cervix uteri. a meta-analysis.","volume":"71","author":"Delgado-Rodriguez","year":"1992","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"1, pt 2","key":"zoi211211r34","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/0002-9378(90)90569-S","article-title":"Past use of oral contraceptives and cardiovascular disease: a meta-analysis in the context of the Nurses\u2019 Health Study.","volume":"163","author":"Stampfer","year":"1990","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"zoi211211r35","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003552.pub2","article-title":"Skin patch and vaginal ring versus combined oral contraceptives for contraception.","author":"Lopez","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"zoi211211r37","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1001\/jama.284.1.72","article-title":"Ischemic stroke risk with oral contraceptives: a meta-analysis.","volume":"284","author":"Gillum","year":"2000","journal-title":"JAMA"},{"issue":"9","key":"zoi211211r38","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1097\/MEG.0000000000000915","article-title":"Exposure to oral contraceptives increases the risk for development of inflammatory bowel disease: a meta-analysis of case-controlled and cohort studies.","volume":"29","author":"Ortizo","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"zoi211211r39","first-page":"915","article-title":"Meta-analysis of oral contraceptives and rheumatoid arthritis risk in women.","volume":"10","author":"Qi","year":"2014","journal-title":"Ther Clin Risk Manag"},{"issue":"11","key":"zoi211211r40","first-page":"3954","article-title":"Oral contraceptive use and kidney cancer risk among women: evidence from a meta-analysis.","volume":"7","author":"Liu","year":"2014","journal-title":"Int J Clin Exp Med"},{"issue":"7","key":"zoi211211r41","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/codi.14582","article-title":"Hormone replacement therapies, oral contraceptives, reproductive factors and colorectal adenoma risk: a systematic review and dose-response meta-analysis of observational studies.","volume":"21","author":"Song","year":"2019","journal-title":"Colorectal Dis"},{"issue":"3","key":"zoi211211r42","article-title":"Depot medroxyprogesterone versus norethisterone oenanthate for long-acting progestogenic contraception.","author":"Draper","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"43","key":"zoi211211r43","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000001619","article-title":"Oral contraceptives use and liver cancer risk: a dose-response meta-analysis of observational studies.","volume":"94","author":"An","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"zoi211211r44","first-page":"59","article-title":"Risk of venous thromboembolism in women taking the combined oral contraceptive: a systematic review and meta-analysis.","volume":"45","author":"Bateson","year":"2016","journal-title":"Aust Fam Physician"},{"issue":"5","key":"zoi211211r45","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1093\/humupd\/dmp017","article-title":"Oral contraceptives and colorectal cancer risk: a systematic review and meta-analysis.","volume":"15","author":"Bosetti","year":"2009","journal-title":"Hum Reprod Update"},{"issue":"2","key":"zoi211211r46","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/humupd\/dmq042","article-title":"Oral contraceptives and risk of endometriosis: a systematic review and meta-analysis.","volume":"17","author":"Vercellini","year":"2011","journal-title":"Hum Reprod Update"},{"issue":"1","key":"zoi211211r47","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1093\/humrep\/deq301","article-title":"The association between the combined oral contraceptive pill and insulin resistance, dysglycemia and dyslipidemia in women with polycystic ovary syndrome: a systematic review and meta-analysis of observational studies.","volume":"26","author":"Halperin","year":"2011","journal-title":"Hum Reprod"},{"issue":"6","key":"zoi211211r48","doi-asserted-by":"publisher","first-page":"E141","DOI":"10.1177\/1076029610391652","article-title":"The risk of venous thrombosis, including cerebral vein thrombosis, among women with thrombophilia and oral contraceptive use: a meta-analysis.","volume":"17","author":"Dayan","year":"2011","journal-title":"Clin Appl Thromb Hemost"},{"issue":"1","key":"zoi211211r49","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3109\/13625187.2011.643836","article-title":"Venous and pulmonary thromboembolism and combined hormonal contraceptives. systematic review and meta-analysis.","volume":"17","author":"Martinez","year":"2012","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"zoi211211r50","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e4944","article-title":"Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis.","volume":"345","author":"Mantha","year":"2012","journal-title":"BMJ"},{"issue":"6","key":"zoi211211r51","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3109\/13625187.2012.715357","article-title":"Oral contraceptive use and risk of breast cancer: a meta-analysis of prospective cohort studies.","volume":"17","author":"Zhu","year":"2012","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"1","key":"zoi211211r52","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/AOG.0b013e318291c235","article-title":"Oral contraceptive pills as primary prevention for ovarian cancer: a systematic review and meta-analysis.","volume":"122","author":"Havrilesky","year":"2013","journal-title":"Obstet Gynecol"},{"key":"zoi211211r53","article-title":"Oral contraceptive used more than 5 years is associated with increased risk of breast cancer: a meta-analysis of 28,776 South East Asian women.","author":"Nindrea","journal-title":"Research Square"},{"issue":"33","key":"zoi211211r54","doi-asserted-by":"publisher","first-page":"4188","DOI":"10.1200\/JCO.2013.48.9021","article-title":"Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis.","volume":"31","author":"Moorman","year":"2013","journal-title":"J Clin Oncol"},{"issue":"2, pt 1","key":"zoi211211r55","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1097\/AOG.0b013e3182994c43","article-title":"Risk of acute thromboembolic events with oral contraceptive use: a systematic review and meta-analysis.","volume":"122","author":"Peragallo Urrutia","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"7","key":"zoi211211r56","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1111\/1756-185X.12413","article-title":"Absence of protective effect of oral contraceptive use on the development of rheumatoid arthritis: a meta-analysis of observational studies.","volume":"17","author":"Chen","year":"2014","journal-title":"Int J Rheum Dis"},{"issue":"3","key":"zoi211211r57","article-title":"Combined oral contraceptives: venous thrombosis.","author":"de Bastos","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"zoi211211r58","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1002\/ijc.28869","article-title":"Hormone replacement therapy and oral contraceptives and risk of oesophageal adenocarcinoma: a systematic review and meta-analysis.","volume":"135","author":"Lagergren","year":"2014","journal-title":"Int J Cancer"},{"issue":"5","key":"zoi211211r59","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/S1701-2163(15)30258-9","article-title":"Association between use of oral contraceptives and folate status: a systematic review and meta-analysis.","volume":"37","author":"Shere","year":"2015","journal-title":"J Obstet Gynaecol Can"},{"key":"zoi211211r60","doi-asserted-by":"publisher","first-page":"993","DOI":"10.3389\/fneur.2019.00993","article-title":"Oral contraceptive use and increased risk of stroke: a dose-response meta-analysis of observational studies.","volume":"10","author":"Li","year":"2019","journal-title":"Front Neurol"},{"issue":"1","key":"zoi211211r61","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.thromres.2015.04.021","article-title":"Current use of oral contraceptives and the risk of first-ever ischemic stroke: a meta-analysis of observational studies.","volume":"136","author":"Xu","year":"2015","journal-title":"Thromb Res"},{"issue":"9","key":"zoi211211r62","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/j.ijom.2015.05.017","article-title":"Effect of oral contraceptive use on the incidence of dry socket in females following impacted mandibular third molar extraction: a meta-analysis.","volume":"44","author":"Xu","year":"2015","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"9","key":"zoi211211r63","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1093\/humrep\/dev160","article-title":"Linear reduction in thyroid cancer risk by oral contraceptive use: a dose-response meta-analysis of prospective cohort studies.","volume":"30","author":"Wu","year":"2015","journal-title":"Hum Reprod"},{"issue":"1","key":"zoi211211r64","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10552-014-0483-2","article-title":"Nonlinear reduction in risk for colorectal cancer by oral contraceptive use: a meta-analysis of epidemiological studies.","volume":"26","author":"Luan","year":"2015","journal-title":"Cancer Causes Control"},{"issue":"1","key":"zoi211211r65","first-page":"1","article-title":"The risk of venous thromboembolism with different generation of oral contraceptives; a systematic review and meta-analysis.","volume":"2","author":"Baratloo","year":"2014","journal-title":"Emerg (Tehran)"},{"issue":"3","key":"zoi211211r66","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/ijgo.2018.141.issue-3","article-title":"A systematic review and meta-analysis of venous thrombosis risk among users of combined oral contraception.","volume":"141","author":"Dragoman","year":"2018","journal-title":"Int J Gynaecol Obstet"},{"issue":"5","key":"zoi211211r67","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00404-018-4723-7","article-title":"Association between oral contraceptives and risk of hemorrhagic stroke: a meta-analysis of observational studies.","volume":"297","author":"Xu","year":"2018","journal-title":"Arch Gynecol Obstet"},{"issue":"10","key":"zoi211211r68","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1177\/2047487318774847","article-title":"Association between progestin-only contraceptive use and cardiometabolic outcomes: a systematic review and meta-analysis.","volume":"25","author":"Glisic","year":"2018","journal-title":"Eur J Prev Cardiol"},{"key":"zoi211211r69","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.thromres.2018.03.005","article-title":"Systematic review and meta-analysis of the association of combined oral contraceptives on the risk of venous thromboembolism: the role of the progestogen type and estrogen dose.","volume":"165","author":"Oedingen","year":"2018","journal-title":"Thromb Res"},{"issue":"2","key":"zoi211211r70","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s11060-017-2725-0","article-title":"Update on the effect of exogenous hormone use on glioma risk in women: a meta-analysis of case-control and cohort studies.","volume":"137","author":"Lan","year":"2018","journal-title":"J Neurooncol"},{"key":"zoi211211r71","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.phrs.2018.11.036","article-title":"Use of oral contraceptives and risk of ulcerative colitis\u2014a systematic review and meta-analysis.","volume":"139","author":"Wang","year":"2019","journal-title":"Pharmacol Res"},{"issue":"1","key":"zoi211211r72","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001778","article-title":"Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis.","volume":"12","author":"Morrison","year":"2015","journal-title":"PLoS Med"},{"issue":"4","key":"zoi211211r73","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003989.pub3","article-title":"20 microg versus >20 microg estrogen combined oral contraceptives for contraception.","author":"Gallo","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"zoi211211r74","article-title":"Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus.","author":"Lopez","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"zoi211211r75","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/cen.2019.90.issue-4","article-title":"Adolescent use of combined hormonal contraception and peak bone mineral density accrual: a meta-analysis of international prospective controlled studies.","volume":"90","author":"Goshtasebi","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"key":"zoi211211r76","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ejogrb.2020.04.053","article-title":"Hormonal contraceptives and the risk of suicide: a systematic review and meta-analysis.","volume":"251","author":"Perez-Lopez","year":"2020","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"8","key":"zoi211211r77","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1111\/aogs.v99.8","article-title":"Levonorgestrel-releasing intrauterine system and breast cancer risk: a systematic review and meta-analysis.","volume":"99","author":"Conz","year":"2020","journal-title":"Acta Obstet Gynecol Scand"},{"key":"zoi211211r78","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ejogrb.2020.02.014","article-title":"Oral contraceptives use and risk of cervical cancer\u2014a systematic review & meta-analysis.","volume":"247","author":"Asthana","year":"2020","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4","key":"zoi211211r79","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/cen.v91.4","article-title":"Effect of the combined oral contraceptive pill and\/or metformin in the management of polycystic ovary syndrome: a systematic review with meta-analyses.","volume":"91","author":"Teede","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"zoi211211r80","article-title":"Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome.","author":"Costello","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"zoi211211r81","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1093\/humrep\/dem005","article-title":"Metformin versus oral contraceptive pill in polycystic ovary syndrome: a Cochrane review.","volume":"22","author":"Costello","year":"2007","journal-title":"Hum Reprod"},{"issue":"6, pt 2","key":"zoi211211r82","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1016\/0002-9378(88)90203-7","article-title":"Risks and mechanisms of cardiovascular events in users of oral contraceptives.","volume":"158","author":"Meade","year":"1988","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"zoi211211r83","first-page":"33","article-title":"Lipid and lipoprotein changes associated with oral contraceptive use: a randomized clinical trial.","volume":"71","author":"Burkman","year":"1988","journal-title":"Obstet Gynecol"},{"issue":"5","key":"zoi211211r84","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.contraception.2004.01.004","article-title":"The combined contraceptive vaginal ring (NuvaRing) and lipid metabolism: a comparative study.","volume":"69","author":"Tuppurainen","year":"2004","journal-title":"Contraception"},{"issue":"5","key":"zoi211211r85","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1172\/JCI116437","article-title":"Effects of low dose oral contraceptives on very low density and low density lipoprotein metabolism.","volume":"91","author":"Walsh","year":"1993","journal-title":"J Clin Invest"},{"issue":"8","key":"zoi211211r86","first-page":"1252","article-title":"ACOG releases guidelines on hormonal contraceptives in women with coexisting medical conditions.","volume":"75","author":"Armstrong","year":"2007","journal-title":"Am Fam Physician"},{"issue":"6","key":"zoi211211r87","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1210\/er.2011-1034","article-title":"Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.","volume":"33","author":"Diamanti-Kandarakis","year":"2012","journal-title":"Endocr Rev"},{"issue":"11","key":"zoi211211r88","first-page":"3327","article-title":"Metabolic effects of oral contraceptives in women with polycystic ovary syndrome.","volume":"80","author":"Korytkowski","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"zoi211211r89","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies.","volume":"72","author":"Antoniou","year":"2003","journal-title":"Am J Hum Genet"},{"issue":"6","key":"zoi211211r90","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1200\/JCO.2005.03.6772","article-title":"Characterization of BRCA1 and BRCA2 mutations in a large United States sample.","volume":"24","author":"Chen","year":"2006","journal-title":"J Clin Oncol"},{"issue":"9-10","key":"zoi211211r91","doi-asserted-by":"publisher","first-page":"657","DOI":"10.2298\/MPNS1010657V","article-title":"The risk of breast cervical, endometrial and ovarian cancer in oral contraceptive users.","volume":"63","author":"Veljkovic","year":"2010","journal-title":"Med Pregl"},{"issue":"6","key":"zoi211211r92","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1177\/014107680309600606","article-title":"Breast cancer and the pill.","volume":"96","author":"Kubba","year":"2003","journal-title":"J R Soc Med"},{"issue":"3","key":"zoi211211r93","doi-asserted-by":"publisher","first-page":"1S","DOI":"10.1016\/S0010-7824(15)30002-0","article-title":"Breast cancer and hormonal contraceptives: further results.","volume":"54","author":"Collaborative Group on Hormonal Factors in Breast Cancer","year":"1996","journal-title":"Contraception"},{"issue":"3","key":"zoi211211r94","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1258\/0007142001903337","article-title":"Health consequences of combined oral contraceptives.","volume":"56","author":"Hannaford","year":"2000","journal-title":"Br Med Bull"},{"issue":"9599","key":"zoi211211r95","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/S0140-6736(07)61684-5","article-title":"Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies.","volume":"370","author":"Appleby","year":"2007","journal-title":"Lancet"},{"key":"zoi211211r96","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4137\/CPath.S487","article-title":"Tumorigenic effects of tamoxifen on the female genital tract.","volume":"1","author":"Nasu","year":"2008","journal-title":"Clin Med Pathol"},{"issue":"5","key":"zoi211211r97","first-page":"2319","article-title":"Levonorgestrel-impregnated intrauterine device reduces occurrence of hyperplastic polyps: a population-based follow-up cohort study.","volume":"34","author":"Arnes","year":"2014","journal-title":"Anticancer Res"},{"issue":"1","key":"zoi211211r98","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.fertnstert.2007.05.033","article-title":"Use of the levonorgestrel-releasing intrauterine system in breast cancer patients.","volume":"90","author":"Trinh","year":"2008","journal-title":"Fertil Steril"},{"issue":"3","key":"zoi211211r99","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/CEJ.0000000000000538","article-title":"Hormonal and reproductive factors and reduction in the risk of colorectal cancer.","volume":"29","author":"Rennert","year":"2020","journal-title":"Eur J Cancer Prev"},{"issue":"4","key":"zoi211211r100","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1001\/jamaoncol.2017.4942","article-title":"Modification of the associations between duration of oral contraceptive use and ovarian, endometrial, breast, and colorectal cancers.","volume":"4","author":"Michels","year":"2018","journal-title":"JAMA Oncol"},{"issue":"11","key":"zoi211211r101","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1038\/sj.bjc.6605965","article-title":"Oral contraceptives, reproductive history and risk of colorectal cancer in the European Prospective Investigation Into Cancer and Nutrition.","volume":"103","author":"Tsilidis","year":"2010","journal-title":"Br J Cancer"},{"issue":"3","key":"zoi211211r103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6503a1","article-title":"U.S. medical eligibility criteria for contraceptive use, 2016.","volume":"65","author":"Curtis","year":"2016","journal-title":"MMWR Recomm Rep"},{"issue":"14","key":"zoi211211r104","doi-asserted-by":"publisher","first-page":"405","DOI":"10.15585\/mmwr.mm6914a3","article-title":"Update to U.S. medical eligibility criteria for contraceptive use, 2016: updated recommendations for the use of contraception among women at high risk for HIV infection.","volume":"69","author":"Tepper","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"zoi211211r102","volume-title":"Medical Eligibility Criteria for Contraceptive Use","author":"World Health Organization","year":"2015"},{"key":"zoi211211r1","unstructured":"United Nations. Contraceptive use by method 2019: data booklet. UN-iLibrary, United Nations; December 2019. Accessed May 15, 2021. https:\/\/www.un-ilibrary.org\/content\/books\/9789210046527"},{"key":"zoi211211r4","unstructured":"Roe? A, Bartz? DA, Douglas? PS. Combined estrogen-progestin contraception: side effects and health concerns. UpToDate. Updated October 20, 2021. Accessed August 7, 2020. https:\/\/www.uptodate.com\/contents\/combined-estrogen-progestin-contraception-side-effects-and-health-concerns"},{"key":"zoi211211r36","doi-asserted-by":"crossref","unstructured":"French? R, Sorhaindo? AM, Van Vliet? HAAM, . Progestogen-releasing intrauterine systems versus other forms of reversible contraceptives for contraception.? Cochrane Database Syst Rev. 2004;(3):CD001776. doi:10.1002\/14651858.CD001776.pub2","DOI":"10.1002\/14651858.CD001776.pub2"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2788119\/brabaharan_2022_oi_211211_1641835524.93921.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T16:13:18Z","timestamp":1700064798000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2788119"}},"subtitle":["An Umbrella Review of Meta-analyses of Randomized Clinical Trials and Cohort Studies"],"short-title":[],"issued":{"date-parts":[[2022,1,14]]},"references-count":104,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1,4]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.43730","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,14]]}}}